
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Revenue | $103.3M | $123.5M | $154.8M | $180M | $209.5M | |
Revenue Growth (YoY) | 25.16% | 19.61% | 25.32% | 16.29% | 16.35% | |
Cost of Revenues | $11.6M | $14.8M | $20.3M | $22.1M | $25M | |
Gross Profit | $91.7M | $108.8M | $134.6M | $158M | $184.5M | |
Gross Profit Margin | 88.75% | 88.04% | 86.92% | 87.74% | 88.09% | |
R&D Expenses | $39M | $51.6M | $57.8M | $64.1M | $70.6M | |
Selling, General & Admin | $85.7M | $113.4M | $144.5M | $173.2M | $192.6M | |
Other Inc / (Exp) | $1.1M | -$300K | $297K | $550K | $5.9M | |
Operating Expenses | $124.7M | $165M | $202.2M | $237.3M | $263.2M | |
Operating Income | -$33.1M | -$56.3M | -$67.7M | -$79.3M | -$78.7M | |
Net Interest Expenses | $7M | $656K | $101K | $43K | $60K | |
EBT. Incl. Unusual Items | -$38.9M | -$57.2M | -$67.5M | -$78.8M | -$72.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1M | $1M | $1M | $1.4M | $1.8M | |
Net Income to Company | -$40M | -$58.2M | -$68.5M | -$80.2M | -$74.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$40M | -$58.2M | -$68.5M | -$80.2M | -$74.7M | |
Basic EPS (Cont. Ops) | -$1.34 | -$2.37 | -$1.53 | -$1.70 | -$1.45 | |
Diluted EPS (Cont. Ops) | -$1.34 | -$2.37 | -$1.53 | -$1.70 | -$1.45 | |
Weighted Average Basic Share | $32.8M | $25.8M | $44.8M | $47.2M | $51.3M | |
Weighted Average Diluted Share | $32.8M | $25.8M | $44.8M | $47.2M | $51.3M | |
EBITDA | -$30M | -$53.7M | -$64.2M | -$76.4M | -$70.5M | |
EBIT | -$32M | -$56.6M | -$67.4M | -$78.8M | -$72.8M | |
Revenue (Reported) | $103.3M | $123.5M | $154.8M | $180M | $209.5M | |
Operating Income (Reported) | -$33.1M | -$56.3M | -$67.7M | -$79.3M | -$78.7M | |
Operating Income (Adjusted) | -$32M | -$56.6M | -$67.4M | -$78.8M | -$72.8M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $28M | $34.9M | $41M | $51.3M | $56.5M | |
Revenue Growth (YoY) | 21.31% | 24.68% | 17.63% | 25.2% | 10.12% | |
Cost of Revenues | $3.4M | $4.7M | $5.9M | $5.7M | $6.9M | |
Gross Profit | $24.6M | $30.2M | $35.1M | $45.6M | $49.7M | |
Gross Profit Margin | 87.87% | 86.66% | 85.56% | 88.93% | 87.87% | |
R&D Expenses | $12.5M | $14.4M | $15.4M | $17.8M | $19.2M | |
Selling, General & Admin | $26.1M | $34.8M | $42.2M | $50.3M | $49.3M | |
Other Inc / (Exp) | $84K | -$556K | $1.4M | $1.5M | $2.1M | |
Operating Expenses | $38.7M | $49.2M | $57.6M | $68.2M | $68.5M | |
Operating Income | -$14.1M | -$19M | -$22.5M | -$22.5M | -$18.8M | |
Net Interest Expenses | $245K | $25K | $25K | -- | $15K | |
EBT. Incl. Unusual Items | -$14.3M | -$19.6M | -$21.1M | -$21M | -$16.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $329K | $265K | $750K | -$14K | $871K | |
Net Income to Company | -$14.6M | -$19.8M | -$21.9M | -$21M | -$17.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$14.6M | -$19.8M | -$21.9M | -$21M | -$17.7M | |
Basic EPS (Cont. Ops) | -$0.40 | -$0.45 | -$0.48 | -$0.42 | -$0.33 | |
Diluted EPS (Cont. Ops) | -$0.40 | -$0.45 | -$0.48 | -$0.42 | -$0.33 | |
Weighted Average Basic Share | $40.1M | $44.3M | $45.8M | $49.8M | $53.6M | |
Weighted Average Diluted Share | $40.1M | $44.3M | $45.8M | $49.8M | $53.6M | |
EBITDA | -$13.3M | -$18.8M | -$20.2M | -$20.6M | -$15.9M | |
EBIT | -$14M | -$19.5M | -$21.1M | -$21M | -$16.8M | |
Revenue (Reported) | $28M | $34.9M | $41M | $51.3M | $56.5M | |
Operating Income (Reported) | -$14.1M | -$19M | -$22.5M | -$22.5M | -$18.8M | |
Operating Income (Adjusted) | -$14M | -$19.5M | -$21.1M | -$21M | -$16.8M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $108.2M | $130.4M | $161M | $190.4M | $214.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $12.3M | $16M | $21.5M | $21.8M | $26.1M | |
Gross Profit | $95.9M | $114.4M | $139.4M | $168.5M | $188.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $42.5M | $53.5M | $58.7M | $66.5M | $71.9M | |
Selling, General & Admin | $91.3M | $122M | $151.9M | $181.4M | $191.6M | |
Other Inc / (Exp) | $1.5M | -$940K | $2.2M | $694K | $6.4M | |
Operating Expenses | $133.8M | $175.5M | $210.6M | $247.9M | $263.5M | |
Operating Income | -$37.9M | -$61.1M | -$71.2M | -$79.4M | -$75M | |
Net Interest Expenses | $5.7M | $436K | $101K | $18K | $75K | |
EBT. Incl. Unusual Items | -$42.1M | -$62.5M | -$69M | -$78.7M | -$68.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.1M | $951K | $1.5M | $591K | $2.7M | |
Net Income to Company | -$43.2M | -$63.5M | -$70.5M | -$79.3M | -$71.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$43.2M | -$63.5M | -$70.5M | -$79.3M | -$71.3M | |
Basic EPS (Cont. Ops) | -$1.40 | -$2.88 | -$1.56 | -$1.64 | -$1.37 | |
Diluted EPS (Cont. Ops) | -$1.40 | -$2.88 | -$1.56 | -$1.64 | -$1.37 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$33.9M | -$59.2M | -$65.6M | -$76.8M | -$65.8M | |
EBIT | -$36.4M | -$62.1M | -$68.9M | -$78.7M | -$68.6M | |
Revenue (Reported) | $108.2M | $130.4M | $161M | $190.4M | $214.7M | |
Operating Income (Reported) | -$37.9M | -$61.1M | -$71.2M | -$79.4M | -$75M | |
Operating Income (Adjusted) | -$36.4M | -$62.1M | -$68.9M | -$78.7M | -$68.6M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $28M | $34.9M | $41M | $51.3M | $56.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3.4M | $4.7M | $5.9M | $5.7M | $6.9M | |
Gross Profit | $24.6M | $30.2M | $35.1M | $45.6M | $49.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $12.5M | $14.4M | $15.4M | $17.8M | $19.2M | |
Selling, General & Admin | $26.1M | $34.8M | $42.2M | $50.3M | $49.3M | |
Other Inc / (Exp) | $84K | -$556K | $1.4M | $1.5M | $2.1M | |
Operating Expenses | $38.7M | $49.2M | $57.6M | $68.2M | $68.5M | |
Operating Income | -$14.1M | -$19M | -$22.5M | -$22.5M | -$18.8M | |
Net Interest Expenses | $245K | $25K | $25K | -- | $15K | |
EBT. Incl. Unusual Items | -$14.3M | -$19.6M | -$21.1M | -$21M | -$16.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $329K | $265K | $750K | -$14K | $871K | |
Net Income to Company | -$14.6M | -$19.8M | -$21.9M | -$21M | -$17.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$14.6M | -$19.8M | -$21.9M | -$21M | -$17.7M | |
Basic EPS (Cont. Ops) | -$0.40 | -$0.45 | -$0.48 | -$0.42 | -$0.33 | |
Diluted EPS (Cont. Ops) | -$0.40 | -$0.45 | -$0.48 | -$0.42 | -$0.33 | |
Weighted Average Basic Share | $40.1M | $44.3M | $45.8M | $49.8M | $53.6M | |
Weighted Average Diluted Share | $40.1M | $44.3M | $45.8M | $49.8M | $53.6M | |
EBITDA | -$13.3M | -$18.8M | -$20.2M | -$20.6M | -$15.9M | |
EBIT | -$14M | -$19.5M | -$21.1M | -$21M | -$16.8M | |
Revenue (Reported) | $28M | $34.9M | $41M | $51.3M | $56.5M | |
Operating Income (Reported) | -$14.1M | -$19M | -$22.5M | -$22.5M | -$18.8M | |
Operating Income (Adjusted) | -$14M | -$19.5M | -$21.1M | -$21M | -$16.8M |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $37.3M | $95.7M | $40.4M | $41.4M | $30.5M | |
Short Term Investments | $19.5M | $110.3M | $127.9M | $112.3M | $116.6M | |
Accounts Receivable, Net | $35.9M | $36.7M | $39.8M | $44.8M | $49.2M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $2.2M | $6.8M | $6.7M | $9.2M | $13.2M | |
Other Current Assets | $266K | $1.7M | $1.5M | $1.2M | $2.1M | |
Total Current Assets | $103.5M | $263M | $229.5M | $224.3M | $228.4M | |
Property Plant And Equipment | $6.5M | $4.3M | $14.4M | $10.2M | $11.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $2.2M | $1.2M | $1.7M | $1.9M | $1.5M | |
Total Assets | $117.2M | $276.7M | $253M | $247.8M | $260.6M | |
Accounts Payable | $2.4M | $1.9M | $1.4M | $4.9M | $2.2M | |
Accrued Expenses | $3.3M | $2.1M | $10.2M | $13.4M | $20.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $3.1M | $3.2M | $1.4M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $72.9M | $90.3M | $95M | $112.5M | $127.3M | |
Long-Term Debt | $24.9M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $103.7M | $93.5M | $102.8M | $117.3M | $133M | |
Common Stock | $259.8M | -- | -- | -- | -- | |
Other Common Equity Adj | $1K | -$195K | -$807K | $56K | $116K | |
Common Equity | -$246.3M | $183.2M | $150.3M | $130.4M | $127.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $13.5M | $183.2M | $150.3M | $130.4M | $127.6M | |
Total Liabilities and Equity | $117.2M | $276.7M | $253M | $247.8M | $260.6M | |
Cash and Short Terms | $56.8M | $206M | $168.3M | $153.6M | $147.2M | |
Total Debt | $24.9M | -- | -- | -- | -- |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $37.3M | $47.7M | $46.2M | $52M | $28M | |
Short Term Investments | $16M | $153.4M | $117.4M | $108.2M | $113.8M | |
Accounts Receivable, Net | $17.4M | $24.6M | $42.2M | $34.6M | $43.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $3.6M | $6.6M | $6M | $9.1M | $9.7M | |
Other Current Assets | $450K | $1.4M | $836K | $1.2M | $2.1M | |
Total Current Assets | $83.2M | $245.3M | $225.5M | $218.3M | $214.3M | |
Property Plant And Equipment | $5.8M | $12M | $14.3M | $10.2M | $13.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $4M | $1.5M | $1.6M | $1.4M | $1.5M | |
Total Assets | $97.8M | $267M | $249.5M | $242.6M | $247M | |
Accounts Payable | $3.4M | $2.6M | $6.9M | $4.1M | $4.6M | |
Accrued Expenses | $2.8M | $2.2M | $2.9M | $8.8M | $12M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $2.7M | $3.1M | $3.1M | $800K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $63.7M | $84.8M | $101.8M | $109.5M | $114.6M | |
Long-Term Debt | $25M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $95.6M | $92.7M | $108.5M | $113.5M | $120.8M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -$1K | -$881K | -$490K | -$215K | $200K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.2M | $174.3M | $141M | $129.1M | $126.2M | |
Total Liabilities and Equity | $97.8M | $267M | $249.5M | $242.6M | $247M | |
Cash and Short Terms | $53.4M | $201.1M | $163.6M | $160.2M | $141.8M | |
Total Debt | $25M | -- | -- | -- | -- |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$40M | -$58.2M | -$68.5M | -$80.2M | -$74.7M | |
Depreciation & Amoritzation | $2M | $2.8M | $3.2M | $2.4M | $2.3M | |
Stock-Based Compensation | $4.7M | $10.8M | $25.8M | $45.8M | $61.3M | |
Change in Accounts Receivable | -$5.5M | -$730K | -$3.5M | -$5.4M | -$4.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$39.2M | -$41.6M | -$41.2M | -$26.9M | -$15.8M | |
Capital Expenditures | $2.8M | $819K | $5.6M | $4.7M | $3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$22.4M | -$92M | -$23.4M | $15.4M | -$4.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $31.4M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$57.4M | -$25M | -- | -- | -- | |
Repurchase of Common Stock | -- | -$9K | -- | -- | -- | |
Other Financing Activities | -- | -$4.9M | -- | -- | -- | |
Cash From Financing | $80.5M | $192.4M | $9.7M | $12.9M | $9.9M | |
Beginning Cash (CF) | $18.8M | $37.8M | $96.2M | $41M | $41.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $18.9M | $58.8M | -$54.8M | $1.5M | -$10.7M | |
Ending Cash (CF) | $37.8M | $96.2M | $41M | $41.9M | $30.5M | |
Levered Free Cash Flow | -$42M | -$42.4M | -$46.8M | -$31.6M | -$18.8M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$14.6M | -$19.8M | -$21.9M | -$21M | -$17.7M | |
Depreciation & Amoritzation | $708K | $739K | $890K | $400K | $851K | |
Stock-Based Compensation | $1.8M | $5.5M | $9.3M | $14.6M | $13.4M | |
Change in Accounts Receivable | $18.6M | $11.8M | -$2.3M | $10.2M | $6.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.2M | -$8.6M | -$7.2M | $1.6M | -$6.8M | |
Capital Expenditures | $230K | $799K | $1.3M | $995K | $1.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $3.2M | -$44.8M | $10.3M | $3.7M | $1.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.4M | -- | -- | -- | -- | |
Cash From Financing | $8K | $6.1M | $2.8M | $5.1M | $2.6M | |
Beginning Cash (CF) | $37.8M | $96.2M | $41M | $41.9M | $30.5M | |
Foreign Exchange Rate Adjustment | -$6K | -$719K | -$103K | -$262K | $268K | |
Additions / Reductions | $53K | -$47.3M | $5.9M | $10.3M | -$2.8M | |
Ending Cash (CF) | $37.9M | $48.2M | $46.8M | $52M | $28M | |
Levered Free Cash Flow | -$3.4M | -$9.4M | -$8.5M | $564K | -$8.6M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$43.2M | -$63.5M | -$70.5M | -$79.3M | -$71.3M | |
Depreciation & Amoritzation | $2.5M | $2.9M | $3.3M | $1.9M | $2.7M | |
Stock-Based Compensation | $5.7M | $14.4M | $29.6M | $51.1M | $60.1M | |
Change in Accounts Receivable | -$4M | -$7.5M | -$17.6M | $7.1M | -$8.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$36.2M | -$47M | -$39.8M | -$18.2M | -$24.2M | |
Capital Expenditures | $1.2M | $1.4M | $6.1M | $4.4M | $3.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$17.3M | -$140.1M | $31.8M | $8.8M | -$7.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $74M | $198.5M | $6.3M | $15.3M | $7.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $20.5M | $11.5M | -$1.7M | $5.9M | -$23.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$37.4M | -$48.4M | -$45.9M | -$22.6M | -$28.1M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$14.6M | -$19.8M | -$21.9M | -$21M | -$17.7M | |
Depreciation & Amoritzation | $708K | $739K | $890K | $400K | $851K | |
Stock-Based Compensation | $1.8M | $5.5M | $9.3M | $14.6M | $13.4M | |
Change in Accounts Receivable | $18.6M | $11.8M | -$2.3M | $10.2M | $6.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.2M | -$8.6M | -$7.2M | $1.6M | -$6.8M | |
Capital Expenditures | $230K | $799K | $1.3M | $995K | $1.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $3.2M | -$44.8M | $10.3M | $3.7M | $1.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.4M | -- | -- | -- | -- | |
Cash From Financing | $8K | $6.1M | $2.8M | $5.1M | $2.6M | |
Beginning Cash (CF) | $37.8M | $96.2M | $41M | $41.9M | $30.5M | |
Foreign Exchange Rate Adjustment | -$6K | -$719K | -$103K | -$262K | $268K | |
Additions / Reductions | $53K | -$47.3M | $5.9M | $10.3M | -$2.8M | |
Ending Cash (CF) | $37.9M | $48.2M | $46.8M | $52M | $28M | |
Levered Free Cash Flow | -$3.4M | -$9.4M | -$8.5M | $564K | -$8.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.